Manganese targets m-aconitase and activates iron regulatory protein 2 in AF5 GABAergic cells

Journal of Neuroscience Research

Volumn 85, Issue 8, 2007, Pages 1797-1809

  Crooks, Daniel R ^a,b   Ghosh, Manik C ^b   Braun Sommargren, Michelle ^a,c   Rouault, Tracey A ^b   Smith, Donald R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Aconitase; AF5 cells; GABA; Iron regulation; Manganese

Indexed keywords

3 NITROPROPIONIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ACONITATE HYDRATASE; ALANINE; CITRIC ACID; FERRITIN; FLUOROCITRIC ACID; GLUTAMIC ACID; GLUTAMINE; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MANGANESE; PARAQUAT; RNA; ROTENONE; TRANSFERRIN RECEPTOR;

AMINO ACID METABOLISM; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FETUS; FIBROBLAST; IN VITRO STUDY; IRON METABOLISM; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; WESTERN BLOTTING;

ACONITATE HYDRATASE; AMINO ACIDS; ANIMALS; CELL LINE, TRANSFORMED; CITRATES; CITRIC ACID; CULTURE MEDIA; CYTOSOL; GAMMA-AMINOBUTYRIC ACID; HOMEOSTASIS; IRON; IRON REGULATORY PROTEIN 1; IRON REGULATORY PROTEIN 2; MANGANESE; MESENCEPHALON; MITOCHONDRIA; PROTEIN BINDING; RATS; RESPONSE ELEMENTS; TRANSFERRIN;

EID: 34249805092     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21321     Document Type: Article

References (51)

1. Ali SF, Duhart HM, Newport GD, Lipe GW, Slikker W Jr. 1995. Manganese-induced reactive oxygen species: comparison between Mn+2 and Mn+3. Neurodegeneration. 4:329-334.
2. Allerson CR, Cazzola M, Rouault TA. 1999. Clinical severity and thermodynamic effects of iron-responsive element mutations in hereditary hyperferritinemia-cataract syndrome. J Biol Chem. 274:26439-26447.
3. Aschner M, Erikson KM, Dorman DC. 2005. Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol. 35(1):1-32.
4. Brouillet EP, Shinobu L, McGarvey U, Hochberg F, Beal MF. 1993. Manganese injection into the rat striatum produces excitotoxic lesions by impairing energy metabolism. Exp Neurol. 120(1):89-94.
5. Butt J, Kim HY, Basilion JP, Cohen S, Iwai K, Philpott CC, Altschul S, Klausner RD, Rouault TA. 1996. Differences in the RNA binding sites of iron regulatory proteins and potential target diversity. Proc Natl Acad Sci U S A. 93:4345-4349.
6. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47:936-942.
7. Chen JY, Tsao GC, Zhao Q, Zheng W. 2001. Differential cytotoxicity of Mn(II) and Mn(III): special reference to mitochondrial [Fe-S] containing enzymes. Toxicol Appl Pharmacol. 175(2):160-168.
8. Ellingsen DG, Haug E, Ulvik RJ, Thomassen Y. 2003. Iron status in manganese alloy production workers. J Appl Toxicol. 23:239-247.
9. Gavin CE, Gunter KK, Gunter TE. 1990. Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem J. 266:329-334.
10. Gavin CE, Gunter KK, Gunter TE. 1992. Mn2+ sequestration by mitochondria and inhibition of oxidative phosphorylation. Toxicol Appl Pharmacol. 115(1):1-5.
11. Gavin CE, Gunter KK, Gunter TE. 1999. Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology. 20:445-453.
12. Guarriero-Bobyleva V, Volpi-Becchi MA, Masini A. 1973. Parallel partial purification of cytoplasmic and mitochondrial aconitate hydratases from rat liver. Eur J Biochem. 34:455-458.
13. Gunter KK, Aschner M, Miller LM, Eliseev R, Salter J, Anderson K, Gunter TE. 2005. Determining the oxidation states of manganese in NT2 cells and cultured astrocytes. Neurobiol Aging. 27:1816-1826.
14. Gunter KK, Aschner M, Miller LM, Eliseev R, Salter J, Anderson K, Hammond S, Gunter TE. 2005. Determining the oxidation states of manganese in PC12 and nerve growth factor-induced PC12 cells. Free Radic Biol Med. 39(2):164-181.
15. Gwiazda RH, Lee D, Sheridan J, Smith DR. 2002. Low cumulative manganese exposure affects striatal GABA but not dopamine. Neurotoxicology. 23(1):69-76.
16. Hanson ES, Rawlins ML, Leibold EA. 2003. Oxygen and iron regulation of iron regulatory protein 2. J Biol Chem. 278:40337-40342.
17. Haugland R. 2001. Handbook of fluorescent probes and research products. Eugene, OR: Molecular Probes, Inc.
18. Iwai K, Klausner RD, Rouault TA. 1995. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14:5350-5357.
19. Kaptain S, Downey WE, Tang C, Philpott C, Haile D, Orloff DG, Harford JB, Rouault TA, Klausner RD. 1991. A regulated RNA binding protein also possesses aconitase activity. Proc Natl Acad Sci U S A. 88:10109-10113.
20. Kennedy MC, Mende-Mueller L, Blondin GA, Beinert H. 1992. Purification and characterization of cytosolic aconitase from beef liver and its relationship to the iron-responsive element binding protein. Proc Natl Acad Sci U S A. 89:11730-11734.
21. Kent TA, Emptage MH, Merkle H, Kennedy MC, Beinert H, Munck E. 1985. Mossbauer studies of aconitase. Substrate and inhibitor binding, reaction intermediates, and hyperfine interactions of reduced 3Fe and 4Fe clusters. J Biol Chem. 260:6871-6881.
22. Kim E, Kim Y, Cheong HK, Cho S, Shin YC, Sakong J, Kim KS, Yang JS, Jin YW, Kang SK. 2005. Pallidal index on MRI as a target organ dose of manganese: structural equation model analysis. Neurotoxicology. 26:351-359.
23. Kwik-Uribe C, Smith DR. 2006. Temporal responses in the disruption of iron regulation by manganese. J Neurosci Res. 83:1601-1610.
24. Kwik-Uribe CL, Reaney S, Zhu Z, Smith D. 2003. Alterations in cellular IRP-dependent iron regulation by in vitro manganese exposure in undifferentiated PC12 cells. Brain Res. 973(1):1-15.
25. Lai JC, Minski MJ, Chan AW, Leung TK, Lim L. 1999. Manganese mineral interactions in brain. Neurotoxicology. 20:433-444.
26. Lauble H, Kennedy MC, Emptage MH, Beinert H, Stout CD. 1996. The reaction of fluorocitrate with aconitase and the crystal structure of the enzyme-inhibitor complex. Proc Natl Acad Sci U S A. 93:13699-13703.
27. Li GJ, Zhao Q, Zheng W. 2005. Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro. Toxicol Appl Pharmacol. 205(2):188-200.
28. Mergler D, Baldwin M. 1997. Early manifestations of manganese neurotoxicity in humans: an update. Environ Res 73(1-2):92-100.
29. Meyron-Holtz EG, Ghosh MC, Rouault TA. 2004. Mammalian tissue oxygen levels modulate iron-regulatory protein activities in vivo. Science. 306:2087-2090.
30. Moellering H, Gruber W. 1966. Determination of citrate with citrate lyase. Anal Biochem. 17:369-376.
31. Olanow CW, Arendash GW. 1994. Metals and free radicals in neurodegeneration. Curr Opin Neurol. 7:548-558.
32. Pal PK, Samii A, Calne DB. 1999. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology. 20(2-3):227-238.
33. Pantopoulos K. 2004. Iron metabolism and the IRE/IRP regulatory system: an update. Ann N Y Acad Sci 1012:1-13.
34. 2) control mammalian iron metabolism by different pathways. Mol Cell Biol. 16:3781-3788.
35. Paulsen RE, Contestabile A, Villani L, Fonnum F. 1987. An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate. J Neurochem. 48:1377-13785.
36. Petrat F, Rauen U, de Groot H. 1999. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology. 29:1171-1179.
37. Reaney SH, Smith DR. 2005. Manganese oxidation state mediates toxicity in PC12 cells. Toxicol Appl Pharmacol. 205:271-281.
38. Rose IA, O'Connell EL. 1967. Mechanism of aconitase action. I. The hydrogen transfer reaction. J Biol Chem. 242:1870-1879.
39. Sanchez JF, Crooks DR, Lee CT, Schoen CJ, Amable R, Zeng X, Florival-Victor T, Morales N, Truckenmiller ME, Smith DR, Freed WJ. 2006. GABAergic lineage differentiation of AF5 neural progenitor cells in vitro. Cell Tissue Res. 324:1-8.
40. Spadoni F, Stefani A, Morello M, Lavaroni F, Giacomini P, Sancesario G. 2000. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp Brain Res. 135:544-551.
41. Speyer JF, Dickman SR. 1956. On the mechanism of action of aconitase. J Biol Chem. 220(1):193-208.
42. Tomas-Camardiel M, Herrera AJ, Venero JL, Cruz Sanchez-Hidalgo M, Cano J, Machado A. 2002. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA expression in the aged manganese-treated rats. Brain Res Mol Brain Res. 103(1-2):116-129.
43. Truckenmiller ME, Vawter MP, Zhang P, Conejero-Goldberg C, Dillon-Carter O, Morales N, Cheadle C, Becker KG, Freed WJ. 2002. AF5, a CNS cell line immortalized with an N-terminal fragment of SV40 large T: growth, differentiation, genetic stability, and gene expression. Exp Neurol. 175:318-337.
44. Villafranca JJ, Mildvan AS. 1971. The mechanism of aconitase action. II. Magnetic resonance studies of the complexes of enzyme, manganese(II), iron(II), and substrates. J Biol Chem. 246:5791-5798.
45. Wang J, Chen G, Pantopoulos K. 2005. Nitric oxide inhibits the degradation of IRP2. Mol Cell Biol. 25:1347-1353.
46. Wolters EC, Huang CC, Clark C, Peppard RF, Okada J, Chu NS, Adam MJ, Ruth TJ, Li D, Calne DB. 1989. Positron emission tomography in manganese intoxication. Ann Neurol. 26:647-651.
47. Zheng W, Ren S, Graziano JH. 1998. Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res. 799:334-342.
48. Zheng W, Zhao Q. 2001. Iron overload following manganese exposure in cultured neuronal, but not neuroglial cells. Brain Res. 897(1-2):175-179.
49. Zheng W, Zhao Q, Slavkovich V, Aschner M, Graziano JH. 1999. Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res. 833(1):125-132.
50. Zwingmann C, Leibfritz D, Hazell AS. 2003. Energy metabolism in astrocytes and neurons treated with manganese: relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis. J Cereb Blood Flow Metab. 23:756-771.
51. Zwingmann C, Leibfritz D, Hazell AS. 2004. Brain energy metabolism in a sub-acute rat model of manganese neurotoxicity: an ex vivo nuclear magnetic resonance study using [1-13C]glucose. Neurotoxicology. 25:573-587.